Brief: Captor Therapeutics Says Preclinical Proof-Of-Concept Trial Results Confirm High Anti-Cancer Activity Of Two Compounds

Captor Therapeutics SA

11/01/2022 17:33

Jan 11 (Reuters) - Captor Therapeutics SA  CTXP.WA :
    * SAYS PRECLINICAL PROOF-OF-CONCEPT TRIAL RESULTS CONFIRM
HIGH
ANTI-CANCER ACTIVITY OF TWO COMPOUNDS DEVELOPED UNDER CT-01
PROJECT
    * SAYS TRIAL CONDUCTED ON XENOGRAFT MOUSE WITH HUMAN LIVER
CANCER
MODEL
    * SAYS CT-01 PROJECT IS FOCUSED ON DEVELOPING TREATMENT FOR
HEPATOCELLULAR CARCINOMA

Source text for Eikon:  ID:nEM9MqQ55a 
Further company coverage:  CTXP.WA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))